Managed Care - October 2010 - (Page SCover1)
The Impact of Molecular Diagnostics on Treatment Pathways, Outcomes, and Cost
Based on an educational symposium at the Academy of Managed Care Pharmacy 22nd Annual Meeting and Showcase, San Diego, April 6, 2010
• Clinical Advances in Treatment Options and Diagnostics to Manage Breast Cancer and Colon Cancer • Impact of Molecular Diagnostics on Health Outcomes and Cost • Role of Molecular Diagnostics in Quality of Care Initiatives
This activity is sponsored by The University of Arizona College of Medicine and College of Pharmacy at the Arizona Health Sciences Center
Volume 19, No. 10 Supplement 4 October 2010
This activity is supported by an educational grant from Genomic Health
If you would like to try to load the digital publication without using Flash Player detection, please click here.